Holen Sie sich die Stockscreener-App
4.58
0.22%
-0.010
Handel nachbörslich:
4.53
-0.05
-1.09%
Schlusskurs vom Vortag:
$4.59
Offen:
$4.58
24-Stunden-Volumen:
2.21M
Relative Volume:
11.13
Marktkapitalisierung:
$84.90M
Einnahmen:
$117.59M
Nettoeinkommen (Verlust:
$-74.85M
KGV:
-1.097
EPS:
-4.175
Netto-Cashflow:
$-34.25M
1W Leistung:
-9.31%
1M Leistung:
+4.09%
6M Leistung:
+36.31%
1J Leistung:
-77.25%
1-Tages-Spanne:
$4.49
$5.11
1-Wochen-Bereich:
$4.49
$5.235
52-Wochen-Spanne:
$3.00
$21.36
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
4.58 | 84.90M | 117.59M | -74.85M | -34.25M | -4.175 |
ABT
Abbott Laboratories
|
94.12 | 163.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
332.71 | 127.55B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.98 | 103.66B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.23 | 65.74B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.78 | 52.27B | 6.30B | 1.07B | 1.09B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical (OM) surges 25.6%: Is this an indication of further gains? - MSN
Outset Medical, Inc. Actuals & Estimates (NASDAQ:OM) - TradingView
OM Forecast — Price Target — Prediction for 2027 - TradingView
Outset Medical Inc (OM) Institutional Confidence - TradingKey
Outset Medical And 2 Other Compelling Penny Stocks For Your Consideration - Sahm
OM.O PE Ratio & Valuation, Is OM.O Overvalued - Intellectia AI
Outset Medical Inc (OM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OM Technical Analysis & Stock Price Forecast - Intellectia AI
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains? - Yahoo Finance
Outset Medical Inc (OM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Outset Medical Secures Multi‑Year HCA Hemodialysis Agreement - TipRanks
Outset Medical Inc (OM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Outset Medical Inc (OM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Outset Medical Inc (OM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Outset Medical Inc (OM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Outset Medical (OM) inks $40M multi‑year HCA deal for Tablo systems - Stock Titan
Outset Medical Inc (OM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Outset Medical Inc (OM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Outset Medical, Inc. (OM) reports Q1 loss, lags revenue estimates - MSN
Outset Medical Inc. (OM) Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesEnergy Earnings Report - newsline.com
Have Insiders Sold Outset Medical Shares Recently? - simplywall.st
Outset Medical Inc. Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 3.17%Share Dilution Risk - newsline.com
Outset Medical Shareholders Back Board and Governance Measures - The Globe and Mail
Outset Medical CFO Renee Gaeta sells $87,299 in stock - Investing.com UK
Law firm investigates Outset Medical officers for possible shareholder duty breaches - Pluang
Director at Outset Medical (OM) receives 10,667-share stock grant - Stock Titan
Outset Medical CFO Renee Gaeta sells $87,299 in stock By Investing.com - Investing.com Canada
Outset Medical (NYSE: OM) director granted 10,667 RSUs in new equity award - Stock Titan
Outset Medical (OM) director receives 10,667-share RSU equity grant - Stock Titan
Outset Medical (OM) director receives 10,667-share RSU-based award - Stock Titan
Outset Medical (OM) director receives 10,667-share equity award grant - Stock Titan
Outset Medical director granted 10,667 shares | OM Insider Trading - Stock Titan
Outset Medical (OM) CFO tax-related share sale follows RSU vesting - Stock Titan
Outset Medical (NASDAQ: OM) reports 2026 shareholder meeting vote results - Stock Titan
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Barchart.com
BML Capital Management, LLC's Outset Medical Inc(OM) Holding History - GuruFocus
Outset Medical | 4: Statement of changes in beneficial ownership of securities-Director Prange Karen - Moomoo
Outset Medical names Derick Elliott commercial chief - Investing.com
OM (NASDAQ) Form 144 notice — 32,856 shares settled from RSUs - Stock Titan
DaVita Gains 21.4% in Three Months: How Should You Play the Stock? - TradingView
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Outset Medical's Marc Nash to Depart as Executive Vice President, R&D, Operations and Service - TradingView
[8-K] Outset Medical, Inc. Reports Material Event - Stock Titan
Outset Medical, Inc. Announces Resignation of Marc Nash from Executive Vice President, R&D, Operations and Service, Effective June 5, 2026 - marketscreener.com
Why Did Outset Medical Stock Tumble Today? - MSN
Outset Medical Inc. (OM) Edges Higher as Stock Holds Above Key Support LevelHigh Volume Stocks - The Legal Advocate
Outset Medical Q1 2026 Earnings: EPS Misses Estimates as Stock Inches HigherProduct Revenue Analysis - newsline.com
Outset Medical Q1 2026 Earnings: EPS Misses Estimates, Stock Edges HigherEarnings Yield Analysis - thelegaladvocate.com
OM Q1 2026 Earnings: EPS Misses Estimates as Outset Medical Posts Wider-Than-Expected Loss; Stock Edges Up - newsline.com
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):